|
|
STAT5 tetramerization in autoimmune-mediated neuroinflammation |
| 1R56AI167972-01 |
|
NIAID |
2022 |
|
|
Functional protein networks underlying T cell growth, proliferation and differentiation |
| 2R01AI123193-06 |
|
NIAID |
2022 |
|
|
Development of a novel accurate therapy for multiple sclerosis |
| 2R42AI141323-02A1 |
|
NIAID |
2022 |
|
|
Targeted in vivo perturbation for dissecting tissue immune responses |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Clinical Core |
| 2U19AI128949-06 |
|
NIAID |
2022 |
|
|
Regulatory T Cells in Alzheimers Disease |
| 3R01AI124512-07S1 |
|
NIAID |
2022 |
|
|
Mechanistic dissection of the link between virus infection and Alzheimer’s disease in a model organism |
| 3R01AI137471-05S1 |
|
NIAID |
2022 |
|
|
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy |
| 3R01AI141526-04S1 |
|
NIAID |
2022 |
|
|
Pathogenesis of Alzheimers Disease upon Borrelia burgdorferi infection in a mouse model system |
| 3R01AI152235-03S1 |
|
NIAID |
2022 |
|
|
Regulation of memory CD8 T cell development |
| 3R37AI066232-18S1 |
|
NIAID |
2022 |